Document is current

Article History

Received: 23 August 2020

Accepted: 17 September 2020

First Online: 23 September 2020

Competing interests

: The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays and NDV-based SARS-CoV-2 vaccines. I would also like to note the following, which could be perceived as a conflict of interest: I have previously published work on influenza virus vaccines with S. Gilbert (University of Oxford), have consulted for Merck and Pfizer (before 2020), my laboratory is collaborating with Pfizer on animal models of SARS-CoV-2, my laboratory is collaborating with N. Pardi at the University of Pennsylvania on mRNA vaccines against SARS-CoV-2, my laboratory was working in the past with GlaxoSmithKline on the development of influenza virus vaccines and one of my mentees has recently joined Moderna.

Free to read: This content has been made available to all.